ARTICLES BY THIS AUTHOR
- 2/1/2023
Cardinal Health reports revenue growth in Q2
Cardinal Health’s second quarter revenue increased 13% to $51.5 billion from the prior year period. - 2/1/2023
AAM applauds CMS for requiring health plans to place generic drugs on tiers
The organization publicly commends the administration’s efforts to standardize plan choice by requiring generic drugs be placed on generic tiers and brand-name drugs on brand-name tiers. - 1/31/2023
Camber intros generic Namenda
Memantine HCl tablets are indicated for the treatment of moderate to severe dementia of Alzheimer’s. - 1/31/2023
Hikma launches naloxone hydrochloride injection
Naloxone hydrochloride injection is used for the emergency treatment of a known or suspected opioid overdose. - 1/31/2023
CVS Health Clinical Trial Services to recruit diabetes, chronic kidney disease patients
Clinical Trial Services will recruit patients at 39 proact 1 (REGEN-006) clinical sites, using a machine learning model to identify patient populations that align with trial inclusion/exclusion criteria. - 1/31/2023
Giant Eagle to modernize in-store product management across 5 states
Giant Eagle aims to use strategic category management technology to improve the customer experience at 216 supermarkets and 274 GetGo convenience stores throughout Pennsylvania, Ohio, West Virginia, Maryland and Indiana. - 1/31/2023
Schnucks kicks off register campaign supporting Urban League
For the third consecutive year, as part of Black History Month in February, Schnuck Markets will offer customers the opportunity to round up at the register to support the Urban League. - 1/30/2023
NACDS kicks off 2023 Regional Chain Conference
In its 90th year, NACDS remains focused on the ever-evolving goal of leading the future of an industry dedicated to advancing health and wellness for all Americans. - 1/30/2023
H-E-B, Costco best navigate pandemic grocery market upheaval, bumping Amazon from top
H-E-B, Costco and Amazon are the three retailers with customer value propositions best built for long-term success, according to Dunnhumby’s 6th annual Retailer Preference Index for U.S. Grocery. - 1/30/2023
Eisai obtains FDA green light for Leqembi
Leqembi is indicated for the treatment of Alzheimer’s disease.